To explicitly clarify the mechanisms underlying the abnormal expression or dysfunction of GSPT1 in cancer, we clarified the upstream regulatory mechanisms, including genomic alterations, transcriptional factors, and microRNA (miRNA), and post‐translational modifications (PTMs). Here, GSPT1 is linked to cancer.